Veterinary Medicines

ORIDERMYL pomada auricular para cães e gatos

Authorised
  • Triamcinolone acetonide
  • Nystatin
  • NEOMYCIN SULFATE
  • Permethrin
Download as PDF

Product identification

Medicine name:
ORIDERMYL pomada auricular para cães e gatos
Active substance:
  • Triamcinolone acetonide
  • Nystatin
  • NEOMYCIN SULFATE
  • Permethrin
Target species:
  • Dog
  • Cat
Route of administration:
  • Auricular use

Product details

Active substance and strength:
  • Triamcinolone acetonide
    0.10
    gram(s)
    /
    1.00
    Tube
  • Nystatin
    10000000.00
    international unit(s)
    /
    1.00
    Tube
  • NEOMYCIN SULFATE
    350000.00
    international unit(s)
    /
    1.00
    Tube
  • Permethrin
    1.00
    gram(s)
    /
    1.00
    Tube
Pharmaceutical form:
  • Ear ointment
Withdrawal period by route of administration:
  • Auricular use
    • Dog
      • Meat and offal
        0
        day
    • Cat
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QS02DC
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Portugal
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Vetoquinol S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vetoquinol S.A.
Responsible authority:
  • Directorate General For Food And Veterinary
Authorisation number:
  • 284/01/10NFVPT
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Portuguese (PDF)
Published on: 23/04/2025
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."